A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.

Johannes Kratz, M.D., a research fellow in the Thoracic Oncology Lab from 2008-11, played a pivotal role in the development of a prognostic assay for early-stage lung cancer patients, reported on in The Lancet and JAMA.
Charles J. Ryan, M.D. is a medical oncologist specializing in the treatment of thoracic and urologic malignancies. As a physician In the Thoracic Oncology Program, Dr. Ryan treats patients with non-small cell lung cancer, small cell lung cancer, BAC, mediastinal tumors and pulmonary metastases.
Dr. Ryan is a member of the UCSF Helen Diller Family Comprehensive Cancer Center where he conducts research investigating the most promising targeted therapies and novel agents for the treatment of cancer. Dr. Ryan has served as a Principal Investigator on a number of clinical trials and has authored numerous articles on molecularly targeted therapies.
Dr. Ryan earned his medical degree at the University of Wisconsin School of Medicine, where he also completed a residency in internal medicine. He then was accepted into a prestigious clinical fellowship program at Memorial Sloan-Kettering Cancer Center (MSKCC) where he received advanced state-of-the-art training in medical oncology. At MSKCC, Dr. Ryan took care of patients with complex and challenging cancers, many of whom had been diagnosed with advanced lung cancer.